Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ISV-305 to vehicle in active, symptomatic blepharitis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISV-305

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Active, Symptomatic Blepharitis | Phase 3 | Status: COMPLETED | Results posted: 2021-03-23